DenovAI Biotech
DenovAI Biotech

DenovAI Biotech

Measured by AhrefsDR8Ahrefs DR: 8/100. Bottom 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent29Agent Readiness: 29/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed84Site Speed: 84/100. Top 25%. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust87Data Trust: 87/100. Top 25%. Measured by StartupHub.ai. Median 61.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

2023Active11Rehovot, Israel

About

DenovAI Biotech designs bespoke proteins from scratch using artificial intelligence and computational molecular biophysics. Their core offerings include developing next-generation therapeutics like high-affinity antibodies and small protein/peptide biologics, as well as diagnostic reporters. They aim to transform human health by creating foundational technology platforms for de novo protein design.

Key facts

Website
denovai.com
Headquarters
Rehovot, Israel
Founded
2023
Employees
11
Business model
B2B

Tech stack

Detected on denovai.com, last scanned 23 Oct 2026.

Email provider
Microsoft 365

DenovAI Biotech scores 8. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is DenovAI Biotech trustworthy and reputable?

StartupHub's Data Trust & Reputation score for DenovAI Biotech is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How many employees does DenovAI Biotech have?

DenovAI Biotech has approximately 11 people on record.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for DenovAI Biotech